NCT07888855Not yet recruiting
Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
A Real World Study of Remote Continuous Noninvasive Monitoring and Diagnosis of Diabetic Kidney Disease Using a Two Dimensional Heterostructure Based Wearable NH₃ Sensor
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
This retrospective study evaluates whether providing clinicians with artificial intelligence (AI)-based kidney function results from a breath ammonia test can improve the quality of medication recommendations made by clinical pharmacists. Using historical inpatient cases from Shanghai Pudong Hospital, each case was evaluated under two information conditions: one with standard clinical information only, and one with the additional AI-based breath test kidney function results. Independent experts blindly scored the medication recommendations. The study aims to determine whether the breath test AI information adds meaningful clinical value to pharmacist decision-making.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 380 (estimated)
- First submitted
- 30 Sept 2026
- Start date
- 9 Oct 2026
- Primary completion date
- 30 Oct 2026
- Lead sponsor
- Shanghai Pudong Hospital
- Diseases
- Chronic kidney disease, Type 2 diabetes
- NCT number
- NCT07888855
What you commit to
- Study type: Observational
- Planned participants: 380
- From 9 Oct 2026 to the primary completion date, 30 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Missing standardized case data preventing independent medication evaluation.
Other illness
- Cases that cannot maintain information isolation between Condition A and Condition B.
Other
- Breath test and reference blood test interval exceeding 7 days.
- Case in acute kidney injury (AKI) state.
Who the study is looking for
- Historical cases with completed breath test and AI kidney function classification results.
- Complete standardized case records from the breath test hospitalization.
- Serum creatinine and eGFR results available within 7 days before or after the breath test, serving as an independent reference standard.
- Case data sufficient to support the pharmacist in making medication recommendations.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Pudong Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.